Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Svetlana Khatkova"'
Autor:
Thierry Lejeune, Svetlana Khatkova, Lynne Turner-Stokes, Philippe Picaut, Pascal Maisonobe, Jovita Balcaitiene, François Constant Boyer
Publikováno v:
Journal of Rehabilitation Medicine, Vol 53, Iss 5, p jrm00187 (2021)
Externí odkaz:
https://doaj.org/article/4e3625cc0408447cae1e57ba0d5077d7
Autor:
Thierry Lejeune, Svetlana Khatkova, Lynne Turner-Stokes, Philippe Picaut, Pascal Maisonobe, Jovita Balcaitiene, François Constant Boyer
Publikováno v:
Journal of Rehabilitation Medicine, Vol 52, Iss 6, p jrm00068 (2020)
Botulinum toxins, such as abobotulinumtoxinA, are used to treat spasticity (muscle overactivity) in arm muscles. Spasticity in shoulder muscles occurs in many patients following a stroke. Shoulder spasticity can be painful and limit limb movement. Th
Externí odkaz:
https://doaj.org/article/9fcca31f905b4fea95c252ebb1c9c6a3
Autor:
A. S. Orlova, O R Orlova, Mikhail A. Akulov, Dmitriy Usachev, Sergej Brankovich Bolevich, V.V. Karnaukhov, Svetlana Khatkova, Mariya V. Kolycheva, Vladimir O. Zakharov, S V Tanyashin, V N Shimanskiy
Publikováno v:
Serbian Journal of Experimental and Clinical Research, Vol 22, Iss 2, Pp 137-144 (2021)
Introduction: Delayed facial palsy (DFP) is a common complication appearing ≥3 days after neurosurgery. In cases where glucocorticoids are contraindicated, other treatments are needed. Methods: The efficacy of BoNT-A injections was evaluated in pat
Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis
Autor:
Robert Jech, Gerard E. Francisco, Pascal Maisonobe, Jean-Michel Gracies, Carl Rios, Svetlana Khatkova
Publikováno v:
Journal of Neurologic Physical Therapy
Supplemental Digital Content is Available in the Text.
Background and Purpose: Guided self-rehabilitation contracts (GSCs) are a diary-based rehabilitation strategy, wherein specific muscles are identified for prescription of high-load, home sel
Background and Purpose: Guided self-rehabilitation contracts (GSCs) are a diary-based rehabilitation strategy, wherein specific muscles are identified for prescription of high-load, home sel
Autor:
M. V. Sidorova, Evgeniy A. Nikolaev, V. Y. Roschin, O. G. Pavlova, V. A. Selionov, Svetlana Khatkova
Publikováno v:
Bulletin of Rehabilitation Medicine. 20:35-44
Aim. We have developed a method for objective assessment of proprioceptive sensitivity (PS) based on determining the accuracy of reproduction with the eyes closed of the tested arm passive single-joint movements by active movements of the other arm d
Publikováno v:
NEUROSCIENCE FOR MEDICINE AND PSYCHOLOGY.
Autor:
Philippe Picaut, Svetlana Khatkova, Steven G Faux, Romain Raymond, Peter McAllister, Jean-Michel Gracies
Publikováno v:
Journal of Rehabilitation Medicine, Vol 51, Iss 10, Pp 813-816 (2019)
Objective To compare walking speed in patients with spastic hemiparesis who received abobotulinumtoxinA either in the lower limb or simultaneously in both the lower and upper limbs. Design Post hoc analysis from a phase 3 study of abobotulinumtoxinA
Autor:
François Boyer, Thierry Lejeune, Jovita Balcaitiene, Pascal Maisonobe, Lynne Turner-Stokes, Svetlana Khatkova, Philippe Picaut
Publikováno v:
Journal of Rehabilitation Medicine, Vol 53, Iss 5, p jrm00187 (2021)
Journal of rehabilitation medicine, Vol. 53, no.5, p. jrm00187 (2021)
Journal of rehabilitation medicine, Vol. 53, no.5, p. jrm00187 (2021)
Botulinum toxins, such as abobotulinumtoxinA, are used to treat spasticity (muscle overactivity) in arm muscles. Spasticity in shoulder muscles occurs in many patients following a stroke. Shoulder spasticity can be painful and limit limb movement. Th
Publikováno v:
Neuroscience for Medicine and Psychology.
Autor:
Nicolas Roche, Carlos Cantú-Brito, Patrik Säterö, Svetlana Khatkova, Wolfgang H. Jost, Susanne Heitmann, Georg Comes, Christine Kliebe-Frisch, Julian Harriss, Olivier Simon
Publikováno v:
Neurologia i neurochirurgia polska. 55(2)
Aim of the study. SPACE, a prospective, non-interventional, open-label, multinational study, investigated physicians’ and subjects’ assessment of safety, efficacy, and health-related quality of life (HRQoL) following botulinum neurotoxin type A (